Pharmaceutical Commerce articleshttps://www.pharmaceuticalcommerce.com/newsPharmaceutical Commerce articles© 2026 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.Tue, 09 Jun 2026 04:58:17 +00005en-us14447https://www.pharmaceuticalcommerce.com/newshttps://www.pharmaceuticalcommerce.com/logo.webphttps://www.pharmaceuticalcommerce.com/view/trumprx-adds-160-more-drugshttps://www.pharmaceuticalcommerce.com/view/trumprx-adds-160-more-drugs<![CDATA[After adding 160 more drugs, TrumpRx tops 800 prescription offerings. Here's what the latest MFN-driven expansion means for pricing and access.]]>Mon, 08 Jun 2026 17:24:52 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/how-ai-and-cgts-are-reshaping-pharma-3plhttps://www.pharmaceuticalcommerce.com/view/how-ai-and-cgts-are-reshaping-pharma-3pl<![CDATA[Danny Williams discusses how AI has moved from experimental pilots to full operational deployment across supply chain functions, and how cell and gene therapies are reshaping the logistics industry.]]>Mon, 08 Jun 2026 13:56:13 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/why-pharma-supply-chains-are-turning-to-aihttps://www.pharmaceuticalcommerce.com/view/why-pharma-supply-chains-are-turning-to-ai<![CDATA[4flow's Natalia Andreyeva breaks down the persistent planning failures driving AI adoption in pharma supply chains.]]>Fri, 05 Jun 2026 14:07:21 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/faq-what-does-the-medicare-glp-1-bridge-mean-for-pharma-https://www.pharmaceuticalcommerce.com/view/faq-what-does-the-medicare-glp-1-bridge-mean-for-pharma-<![CDATA[A new CMS demonstration launching July 1 will offer eligible Part D beneficiaries access to branded obesity drugs at a $50 copay. Here's what manufacturers, payers, and pharmacies need to know.]]>Fri, 05 Jun 2026 12:00:00 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/faq-the-medicare-glp-1-bridge-programhttps://www.pharmaceuticalcommerce.com/view/faq-the-medicare-glp-1-bridge-program<![CDATA[CMS's Medicare GLP-1 Bridge launches July 1, giving eligible Part D beneficiaries access to branded obesity drugs at a $50 copay — outside the standard Part D benefit.]]>Fri, 05 Jun 2026 12:00:00 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/why-pharma-3pls-are-rethinking-their-role-in-drug-commercializationhttps://www.pharmaceuticalcommerce.com/view/why-pharma-3pls-are-rethinking-their-role-in-drug-commercialization<![CDATA[EVERSANA's Danny Williams breaks down the most consequential operational shifts in pharma 3PL over the past five years, from full-pallet distribution to integrated commercialization support for complex, targeted therapies. ]]>Thu, 04 Jun 2026 14:49:09 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/pharma-pulse-hospital-pharmacy-s-340b-fears-and-the-fda-s-gene-therapy-fast-lanehttps://www.pharmaceuticalcommerce.com/view/pharma-pulse-hospital-pharmacy-s-340b-fears-and-the-fda-s-gene-therapy-fast-lane<![CDATA[In this week's Pharma Pulse, a Bluesight survey flags hospital pharmacy's top concerns, the Wegovy pill is introduced to the UAE, and more.]]>Thu, 04 Jun 2026 10:00:00 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/next-generation-hub-services-patient-support-providerhttps://www.pharmaceuticalcommerce.com/view/next-generation-hub-services-patient-support-provider<![CDATA[Streamlined hub services, clinical navigators, and data-driven field reimbursement are transforming the rare disease patient journey.]]>Wed, 03 Jun 2026 17:50:46 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/wegovy-pills-uae-debut-is-a-distribution-story-not-just-a-market-entryhttps://www.pharmaceuticalcommerce.com/view/wegovy-pills-uae-debut-is-a-distribution-story-not-just-a-market-entry<![CDATA[Novo Nordisk's UAE launch of the Wegovy pill signals a new phase of oral GLP-1 commercialization, with major implications for pharma distribution, channel strategy, and international market access.]]>Wed, 03 Jun 2026 15:39:19 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/dr-reddys-ceo-on-generic-semaglutide-and-the-glp-1-market-aheadhttps://www.pharmaceuticalcommerce.com/view/dr-reddys-ceo-on-generic-semaglutide-and-the-glp-1-market-ahead<![CDATA[Erez Israeli explains how Dr. Reddy's approached commercial readiness for its generic semaglutide launch in Canada and what vertical integration in peptide manufacturing means for the GLP-1 market.]]>Wed, 03 Jun 2026 13:00:00 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/pharmaceutical-logistics-finding-shipping-solutions-that-match-your-level-of-precision-and-care-may-2026https://www.pharmaceuticalcommerce.com/view/pharmaceutical-logistics-finding-shipping-solutions-that-match-your-level-of-precision-and-care-may-2026<![CDATA[This eBook highlights Werner’s premium and expedited shipping solutions designed specifically to address the high-stakes requirements of the $1.6 trillion global pharmaceutical industry. It details how their specialized multimodal services—including 24/7 dedicated operational teams and experienced driver networks—mitigate risks for high-value, perishable and time-sensitive medical freight.]]>Wed, 03 Jun 2026 04:00:00 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/beyond-the-dashboard-why-certification-is-the-new-currency-in-pharma-logisticshttps://www.pharmaceuticalcommerce.com/view/beyond-the-dashboard-why-certification-is-the-new-currency-in-pharma-logistics<![CDATA[This article examines the growing importance of certifications as a defining standard in pharmaceutical logistics. As regulatory scrutiny intensifies and supply chains become more complex, certifications signal a provider’s ability to meet stringent quality, compliance, and handling requirements. From GDP compliance and specialized training to validated processes and audit readiness, explore how certified logistics partners go beyond basic visibility tools to deliver trust, accountability, and risk mitigation. The piece also highlights how shippers can evaluate partners based on credentials that ensure consistent performance and safeguard sensitive pharmaceutical products throughout the supply chain.]]>Wed, 03 Jun 2026 04:00:00 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/how-the-cencora-kite-deal-can-reduce-time-to-therapyhttps://www.pharmaceuticalcommerce.com/view/how-the-cencora-kite-deal-can-reduce-time-to-therapy<![CDATA[Cencora will support US distribution of Kite's Yescarta and Tecartus, reducing administrative burdens and expanding CAR T-cell therapy access at authorized treatment centers.]]>Tue, 02 Jun 2026 16:53:52 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/a-biopharma-perspective-on-what-s-next-in-access-affordabilityhttps://www.pharmaceuticalcommerce.com/view/a-biopharma-perspective-on-what-s-next-in-access-affordability<![CDATA[Learn how to navigate growing complexity, reduce workflow fragmentation, and design access and affordability programs that support patients throughout their treatment journey.]]>Tue, 02 Jun 2026 15:54:01 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/why-pharma-needs-to-rethink-its-path-to-the-patienthttps://www.pharmaceuticalcommerce.com/view/why-pharma-needs-to-rethink-its-path-to-the-patient<![CDATA[Cameron Olig explains how transparency and direct access models can help pharma close the gap between drug pricing, distribution and the patient.]]>Tue, 02 Jun 2026 15:53:21 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/thermosafe-expands-us-based-vip-manufacturinghttps://www.pharmaceuticalcommerce.com/view/thermosafe-expands-us-based-vip-manufacturing<![CDATA[ThermoSafe expands US VIP manufacturing amid surging biologics demand and growing pressure to reduce overseas cold chain packaging risk.]]>Tue, 02 Jun 2026 13:01:24 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/first-oral-post-exposure-covid-19-prevention-drug-approved-by-fdahttps://www.pharmaceuticalcommerce.com/view/first-oral-post-exposure-covid-19-prevention-drug-approved-by-fda<![CDATA[FDA approves Shionogi's Xocova, the first oral post-exposure COVID-19 prevention therapy, reducing infection risk by 67% in Phase III trials. ]]>Mon, 01 Jun 2026 17:24:56 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/minimum-viable-launch-maximum-patient-pull-throughhttps://www.pharmaceuticalcommerce.com/view/minimum-viable-launch-maximum-patient-pull-through<![CDATA[Early launch planning, streamlined patient access, and measured AI adoption help specialty therapy programs accelerate treatment and sustain success.]]>Mon, 01 Jun 2026 12:56:36 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/cvs-caremark-expands-glp-1-formulary-coveragehttps://www.pharmaceuticalcommerce.com/view/cvs-caremark-expands-glp-1-formulary-coverage<![CDATA[The PBM’s updated commercial formularies reflect negotiated pricing progress with manufacturers.]]>Fri, 29 May 2026 13:11:40 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/why-unpredictable-access-is-a-commercial-risk-biopharma-can-t-ignorehttps://www.pharmaceuticalcommerce.com/view/why-unpredictable-access-is-a-commercial-risk-biopharma-can-t-ignore<![CDATA[As specialty drug launches grow, pharma leaders are rethinking patient access as a core commercialization strategy to reduce delays and improve therapy starts.]]>Fri, 29 May 2026 12:00:00 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/how-reusable-plastic-pallets-help-foster-traceability-and-securityhttps://www.pharmaceuticalcommerce.com/view/how-reusable-plastic-pallets-help-foster-traceability-and-security<![CDATA[]]>Thu, 28 May 2026 13:57:51 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/pharma-pulse-pbm-crackdowns-and-lilly-s-3-8b-vaccine-spreehttps://www.pharmaceuticalcommerce.com/view/pharma-pulse-pbm-crackdowns-and-lilly-s-3-8b-vaccine-spree<![CDATA[In this week's Pharma Pulse, House committees advance key legislation targeting PBM kickbacks and pharmacy access, Macfarlane Packaging partners with eutecma to bring modular cold chain solutions to the UK, and more.]]>Thu, 28 May 2026 10:00:00 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/how-rfid-enabled-mira-care-can-bolster-hospital-cold-storage-resiliencehttps://www.pharmaceuticalcommerce.com/view/how-rfid-enabled-mira-care-can-bolster-hospital-cold-storage-resilience<![CDATA[Intelliguard and Accucold have launched an RFID-enabled refrigerated cabinet to improve hospital medication tracking, visibility, and cold-chain control.]]>Wed, 27 May 2026 14:47:13 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/what-causes-generic-drug-shortages-https://www.pharmaceuticalcommerce.com/view/what-causes-generic-drug-shortages-<![CDATA[Generic drug shortages may seem sudden, but they stem from ongoing pressures in manufacturing, pricing, and global supply chains, especially in hospitals.]]>Wed, 27 May 2026 12:00:00 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/when-patient-safety-depends-on-data-how-ai-is-reshaping-dscsa-compliancehttps://www.pharmaceuticalcommerce.com/view/when-patient-safety-depends-on-data-how-ai-is-reshaping-dscsa-compliance<![CDATA[The US DSCSA requires digital drug traceability to ensure patient safety, but supply chains face data errors; deploying AI adds an intelligent compliance layer to automate process tracking and protect drug access.]]>Tue, 26 May 2026 15:01:46 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/how-digital-strategies-transform-pharma-supply-chains-in-2026https://www.pharmaceuticalcommerce.com/view/how-digital-strategies-transform-pharma-supply-chains-in-2026<![CDATA[Pharma supply chains are embracing AI, digital twins, IoT, and DSCSA-driven traceability to improve resilience, visibility, and profitability amid rising global disruptions.]]>Tue, 26 May 2026 12:34:52 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/how-proof-of-use-boosts-patient-and-commercial-outcomeshttps://www.pharmaceuticalcommerce.com/view/how-proof-of-use-boosts-patient-and-commercial-outcomes<![CDATA[Kieran Daly discusses how adherence programs can improve patient outcomes, support specialty pharmacy performance, and reduce healthcare costs.]]>Fri, 22 May 2026 17:00:57 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/the-great-repricing-how-self-pay-cash-fits-in-commercialization-strategyhttps://www.pharmaceuticalcommerce.com/view/the-great-repricing-how-self-pay-cash-fits-in-commercialization-strategy<![CDATA[Cash pay is re-emerging as biopharma brands rethink insurance barriers, patient access, and affordability in a fragmented payer market.]]>Fri, 22 May 2026 13:11:10 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/bms-claude-agreement-signals-ai-integration-shift-in-pharmahttps://www.pharmaceuticalcommerce.com/view/bms-claude-agreement-signals-ai-integration-shift-in-pharma<![CDATA[BMS will deploy enterprise AI across functions to streamline workflows, structure field insights, and improve HCP engagement and execution.]]>Thu, 21 May 2026 16:20:21 GMTPharmaceutical CommerceusPharmaceutical Commerce Articleshttps://www.pharmaceuticalcommerce.com/view/q-a-how-rwe-is-reshaping-specialty-pharma-market-accesshttps://www.pharmaceuticalcommerce.com/view/q-a-how-rwe-is-reshaping-specialty-pharma-market-access<![CDATA[Tommy Bramley explains how real-world evidence is reshaping how specialty pharma demonstrates value — from trial design to payer negotiations and patient outcomes.]]>Thu, 21 May 2026 14:08:02 GMTPharmaceutical CommerceusPharmaceutical Commerce Articles